Abstract
We report a case of metallic prosthetic valve thrombosis in a 24-year-old woman at her 36th week of gestation. With the onset of gestation this patient had been prescribed enoxaparin at a once-daily dose of 0.6 mL, which was lower than the recommended dose. The patient's mitral valve gradient was increased. We gave her intravenous unfractionated heparin because she refused to give consent for thrombolytic therapy owing to its potential hazards for the fetus. After the patient gave birth we treated her with a thrombolytic agent and the thrombus completely dissolved. Pregnancy in patients with mechanical valve prosthesis requires close follow-up and patient adherence to the prescribed medications. In case of thrombus formation both the fetus and the mother are at risk for fatal complications.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
